🔎 Trials Near Me

Beranda › Kelebihan Berat Badan › Distrik Columbia › Washington

Uji klinis Kelebihan Berat Badan di Washington, DC

19 studi untuk Kelebihan Berat Badan mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)

Menerima pesertaFase 2Sukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 60 · Wanita · Diperbarui 2 Okt 2026 · NCT03407079

Physical and Behavioral Traits of Overweight and Obese Adults

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00428987

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Menerima pesertaFase 3
  • Med Home Development Grp, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07668414

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Beltsville · 12 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Menerima pesertaFase 3
  • Capital Digestive Care - Chevy Chase, Chevy Chase · 8 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Menerima pesertaFase 3
  • Capital Digestive Care - Chevy Chase, Chevy Chase · 8 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Menerima pesertaFase 3
  • Flourish Research - Bowie, Bowie · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07369011

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville · 6 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Menerima pesertaFase 3
  • Research Site, Lanham · 11 mi jauhnya
  • Research Site, Beltsville · 12 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

Menerima peserta
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06044935

Plant-Based Online Weight Loss Through Education and Resources Program and Study

Menerima peserta
  • Physicians Committee for Responsible Medicine, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07095543

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Children's National Hospital (CNH), Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 12 hingga 25 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06730113

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Washington D.C.
  • AURORA-2 Clinical Site, Bowie · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 3
  • AURORA-1 Clinical Site, Washington D.C.
  • AURORA-1 Clinical Site, Bowie · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Menerima pesertaFase 3
  • Emerson Clinical Research Institute, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Silver Spring · 7 mi jauhnya
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

Prebiotic Inulin for Late-Reproductive Individuals

Menerima peserta
  • Milken Institute School of Public Health, Washington D.C.
Usia 40 hingga 55 · Wanita · Diperbarui 11 Agu 2026 · NCT07724522

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Menerima pesertaFase 3
  • ACCOMPLISH-1 Research Site, Silver Spring · 7 mi jauhnya
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361

Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change

Menerima peserta
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06325722

Uji klinis Kelebihan Berat Badan di kota lain

Studi lain di Washington

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.